Relapsing Secondary Spontaneous Pneumothorax during COVID-19 infection

Main Article Content

Nilay Embel
Muhammed Ziya Öcal
İsmail Ertuğrul Gedik

Abstract

Objective: COVID-19 infection has been reported to cause spontaneous pneumothorax with variable clinical manifestations and prognoses. We would like to present a case of a patient who developed spontaneous pneumothorax during COVID-19 infection.


Case Presentation: A 40-year-old male patient developed spontaneous pneumothorax during COVID-19 infection. A prolonged air leak developed and the patient was discharged with a Heimlich valve. Then the pneumothorax relapsed twice. The surgical treatment of pneumothorax was postponed because of a persistently increased state of inflammation secondary to COVID-19 infection. Our patient recovered completely with carefully timed surgical intervention.


Conclusion: Surgery for the treatment of cases with pneumothoraces during COVID-19 infection has been reported to be as low as 2% compared to 25% in standard pneumothorax admissions. This might be secondary to the generally less favorable general conditions and higher morbidity and mortality of the COVID-19 patients in contrast to the general population who develop spontaneous pneumothorax. The diagnosis and management of these patients may become challenging as symptoms and signs of spontaneous pneumothorax tend to be similar to COVID-19 and these patients may require tailored management.

Downloads

Download data is not yet available.

Article Details

How to Cite
Embel, N., Öcal, M. Z., & Gedik, İsmail E. (2022). Relapsing Secondary Spontaneous Pneumothorax during COVID-19 infection. Medical Science and Discovery, 9(5), 307–309. https://doi.org/10.36472/msd.v9i5.723
Section
Case Reports
Received 2022-04-18
Accepted 2022-05-14
Published 2022-05-27

References

Wang W, Gao R, Zheng Y, Jiang L. COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema. J Travel Med. 2020 20;27(5):taaa062. doi: 10.1093/jtm/taaa062. DOI: https://doi.org/10.1093/jtm/taaa062

Huan NC, Sidhu C, Thomas R. Pneumothorax: classification and etiology. Clin Chest Med. 2021;42(4):711-727. doi: 10.1016/j.ccm.2021.08.007. DOI: https://doi.org/10.1016/j.ccm.2021.08.007

Quincho-Lopez A, Quincho-Lopez DL, Hurtado-Medina FD. Case Report: pneumothorax and pneumomediastinum as uncommon complications of COVID-19 Pneumonia-Literature Review. Am J Trop Med Hyg. 2020;103(3):1170-1176. doi: 10.4269/ajtmh.20-0815. DOI: https://doi.org/10.4269/ajtmh.20-0815

Martinelli AW, Ingle T, Newman J, Nadeem I, Jackson K, Lane ND, et al. COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J. 2020;56(5):2002697. doi: 10.1183/13993003.02697-2020. DOI: https://doi.org/10.1183/13993003.02697-2020

Schnell J, Koryllos A, Lopez-Pastorini A, Lefering R, Stoelben E. Spontaneous pneumothorax. Dtsch Arztebl Int. 2017;114(44):739-744. doi: 10.3238/arztebl.2017.0739. DOI: https://doi.org/10.3238/arztebl.2017.0739

Wong A, Galiabovitch E, Bhagwat K. Management of primary spontaneous pneumothorax: a review. ANZ J Surg. 2019;89(4):303-308. doi: 10.1111/ans.14713. DOI: https://doi.org/10.1111/ans.14713